section name header

Indications ⬇

REMS

Unlabeled Use:

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CV: ARRHYTHMIAS, HF, chest pain.

EENT: blurred vision, visual disturbances.

GI: anorexia, constipation, drug-induced hepatitis, nausea, stomach pain, vomiting.

Derm: rash.

Neuro: dizziness, anxiety, depression, fatigue, headache, tremor.

Interactions ⬆ ⬇

Drug-Drug:

Drug-Food:

Availability ⬆ ⬇

(Generic available)

Route/Dosage ⬆ ⬇

Ventricular Tachycardia

Renal Impairment

Paroxysmal Supraventricular Tachycardia/Paroxysmal Atrial Fibrillation/Flutter

Atrial Fibrillation Conversion (unlabeled)

Action ⬆ ⬇

Therapeutic Effects:

Classifications ⬆ ⬇

Therapeutic Classification: antiarrhythmics (class IC)

Pharmacokinetics ⬆ ⬇

Absorption: Well absorbed from the GI tract following oral administration.

Distribution: Widely distributed to tissues.

Metabolism/Excretion: Mostly metabolized by liver; 30% excreted unchanged by kidneys.

Half-life: 11–14 hr.

Canadian Brand Names ⬆ ⬇

Tambocor

Time/Action Profile ⬆ ⬇

(antiarrhythmic effects)

ROUTEONSETPEAKDURATION
POdaysdays–weeks12 hr

Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆ ⬇

FLEK-a-nide

Code ⬆

NDC Code*